Clinical Trials Directory

Trials / Unknown

UnknownNCT03226483

Intraoperative Radiotherapy After the Resection of Brain Metastases

Intraoperative Radiotherapy After the Resection of Brain Metastases - a Phase II Feasibility Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Universitätsmedizin Mannheim · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

INTRAMET examines prospectively the effectiveness of an intraoperative radiotherapy immediate after the surgical resection of brain metastases. Patients won't receive further radiation therapy of the intraoperatively treated lesion.

Detailed description

Brain metastases occur in up to 40% of all patients diagnosed with systemic cancer. Without adjuvant radiotherapy after resection of space occupying lesions local recurrence rates are high. That is why guidelines recommend a cavity boosting with x-rays. External beam radiotherapy can lower the risk of local recurrence but means longer hospitalization, prolongs the time to systemic salvage therapies and bears risks of radionecrosis and leucoencephalopathy with neurological and cognitive decline. A solution for this problem could be onetime intraoperative radiotherapy (IORT) with soft x-rays to sterilize the resection cavity, which may provide both: freedom from local recurrence fast track salvage therapy initiation. INTRAMET is a single institution, open-label, prospective, phase 2 feasibility study for intraoperative radiotherapy immediately following resection of brain metastases. 50 adult patients with resectable not dural brain metastases should be treated in surgery after tumor resection with IORT with 20-30Gy prescribed to the margin of the resection cavity. The highest dose tolerable to surrounding risk structures (N. opticus, brainstem) should be used. With this method, the investigators hope to show similar local control rates to postoperative external beam radiotherapy in line with guideline recommendations with less patient hospitalization and faster start of rescue therapies which could lead to a favorable overall outcome and less cognitive side effects.

Conditions

Interventions

TypeNameDescription
RADIATIONIntraoperative RadiotherapyIntraoperative Radiotherapy is performed with a mobile radiation device emitting soft energy x-rays in a spherical way. Different size applicators are available to cover the resection cavity after the tightest fit rule.

Timeline

Start date
2017-03-28
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2017-07-21
Last updated
2022-06-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03226483. Inclusion in this directory is not an endorsement.